PYXS – pyxis oncology, inc. (US:NASDAQ)
Stock Stats
News
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201
Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside [Yahoo! Finance]
Pyxis Oncology, Inc. (NASDAQ: PYXS) is now covered by analysts at Stephens. They set an "overweight" rating and a $13.00 price target on the stock.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ:PYXS)
Form S-8 Pyxis Oncology, Inc.
Form SC 13G/A Pyxis Oncology, Inc. Filed by: Laurion Capital Management LP
Form 8-K Pyxis Oncology, Inc. For: Nov 12
Form 10-Q Pyxis Oncology, Inc. For: Sep 30
Form SC 13G/A Pyxis Oncology, Inc. Filed by: Bayer World Investments B.V.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.